secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvex, Inc. (MOVE)
CIK:        0001734750
Form:       8-K
Filed at:   2022-05-12T23:59:59+00:00
Accession:  0001213900-22-025983
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Movano Q1 net loss $6.9M; validates SoC for glucose, BP; beta on track for 2H 2022
--------------------------------------------------------------------------------

- Net loss of $6.9M ($0.21/share) vs $8.1M ($1.01/share) in Q1 2021; operating loss $6.9M.
- Cash and investments $27.7M as of Mar 31, 2022, down from $33.6M at Dec 31, 2021.
- Validated proprietary mmWave SoC for non-invasive glucose and cuffless blood pressure monitoring.
- Hired go-to-market leadership team; added Nan Kirsten Forte to Board; plans limited beta release in 2H 2022.
- No revenue generated; company remains development stage with R&D focus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1734750/000121390022025983/0001213900-22-025983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1734750/000121390022025983/ea159721-8k_movano.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-025983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer